XML 46 R5.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Cash Flows
$ in Thousands
 9 Months Ended
Sep. 30, 2022
USD ($)
Sep. 30, 2021
USD ($)
Cash flows from operating activities    
Net (loss) income $ (24,148) $ 12,755
Adjustments to reconcile net (loss) income to net cash provided by operating activities:    
Depreciation and amortization 76,606 60,484
Provision for doubtful accounts and sales returns 4,374 7,992
Stock-based compensation expense 83,659 89,480
Deferred taxes (21,672) 400
Amortization of deferred financing costs and discount 1,827 1,234
Other non-cash adjustments 5,677 (527)
Changes in operating assets and liabilities, net of acquisition and disposal of businesses:    
Accounts receivable 9,998 (18,779)
Prepaid expenses and other assets 22,246 (14,169)
Trade accounts payable 14,435 10,728
Accrued expenses and other liabilities (7,028) 2,790
Deferred revenue 23,832 17,400
Net cash provided by operating activities 189,806 169,788
Cash flows from investing activities    
Purchase of property and equipment (10,512) (8,332)
Capitalized software and content development costs (42,757) (29,661)
Purchase of net assets of acquired companies, net of cash and restricted cash acquired (20,945) 0
Proceeds from Divestiture of Businesses 6,426 0
Net cash used in investing activities (67,788) (37,993)
Cash flows from financing activities    
Proceeds from issuance of debt 126,900 128,300
Payments on debt (229,442) (131,272)
Stock issuance costs (1,205) 0
Employee taxes paid for withheld shares upon equity award settlement (36,057) (39,012)
Change in due to customers (243,109) (386,973)
Change in customer funds receivable (1,291) (5,838)
Purchase of treasury stock 0 (98,353)
Net cash used in financing activities (384,204) (533,148)
Effect of exchange rate on cash, cash equivalents and restricted cash (14,235) 97
Net decrease in cash, cash equivalents and restricted cash (276,421) (401,256)
Cash, cash equivalents and restricted cash, beginning of period 651,762 644,969
Cash, cash equivalents and restricted cash, end of period 375,341 $ 243,713
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Abstract]    
Cash and cash equivalents 31,413  
Total restricted cash 343,928  
Total cash, cash equivalents and restricted cash in the statement of cash flows $ 375,341